Logo image of AVBP

ARRIVENT BIOPHARMA INC (AVBP) Stock Income Statement

NASDAQ:AVBP - Nasdaq - US04272N1028 - Common Stock - Currency: USD

27.07  -0.32 (-1.17%)

After market: 27.07 0 (0%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

 TTM
(2024-9-30)		 2023
(2023-12-31)		 2022
(2022-12-31)		 2021
(2021-12-31)
Revenue
AVBP Revenue ChartAVBP Revenue over time chart
0.000.000.000.00
Operating Expenses
AVBP Operating Expenses ChartAVBP Operating Expenses over time chart
93.72M74.59M36.91M8.70M
Research and Development
AVBP Research and Development ChartAVBP Research and Development over time chart
78.85M64.88M30.43M6.43M
Selling, General, and Administrative Expenses
AVBP Selling, General, and Administrative Expenses ChartAVBP Selling, General, and Administrative Expenses over time chart
14.87M9.71M6.47M2.26M
Operating Income
AVBP Operating Income ChartAVBP Operating Income over time chart
-93.72M-74.59M-36.91M-8.70M
Interest Income/Expense
AVBP Interest Income/Expense ChartAVBP Interest Income/Expense over time chart
12.67M5.26MN/AN/A
Non Recurring Items
AVBP Non Recurring Items ChartAVBP Non Recurring Items over time chart
N/AN/A0.00-42.91M
Income Before Taxes
AVBP Income Before Taxes ChartAVBP Income Before Taxes over time chart
-81.05M-69.33M-36.91M-51.61M
Net Income
AVBP Net Income ChartAVBP Net Income over time chart
-81.05M-69.33M-36.91M-51.61M
 
Per Share Data
EPS Diluted Total Ops
AVBP EPS Diluted Total Ops ChartAVBP EPS Diluted Total Ops over time chart
-2.62-2.17-1.15-1.61
 
Statistics

All data in USD

Charts

AVBP Income Statement data chartAVBP Revenue, Operating Income, Net Income and EBITDA ChartIncome Statements 2021 2022 2023 TTM -20M -40M -60M -80M
AVBP Earnings Per Share (EPS) chartAVBP EPS Diluted and non-GAAP ChartEarnings Per Share 2021 2022 2023 TTM -0.5 -1 -1.5 -2 -2.5